New combo eye shot aims to halt diabetic vision loss
NCT ID NCT05151744
Summary
This study tested whether adding a new drug called vamikibart to a standard eye injection (ranibizumab) works better for diabetic macular edema (DME) than the standard injection alone. DME is a swelling in the back of the eye that can cause vision loss in people with diabetes. The 76-week study involved 187 people to see if the combination was safe and more effective at improving and preserving vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Bay Area Retina Associates
Walnut Creek, California, 94598, United States
-
Buenos Aires Mácula
Ciudad Autonoma Buenos Aires, C1061AAE, Argentina
-
Caminomed
Tarnowskie Góry, 42-600, Poland
-
Centro Oftalmológico Dr. Charles S.A.
Capital Federal, C1116, Argentina
-
Centrum Diagnostyki i Mikrochirurgii Oka LENS
Olsztyn, 10-424, Poland
-
Centrum Medyczne UNO-MED
Krakow, 31-070, Poland
-
Clinica Universitaria de Navarra
Pamplona, Navarre, 31008, Spain
-
Clinica Universitaria de Navarra
Madrid, 28027, Spain
-
Cumberland Valley Retina Consultants
Hagerstown, Maryland, 21740, United States
-
Deep Blue Retina PLLC
Southaven, Mississippi, 38671, United States
-
Emanuelli Research and Development Center LLC
Arecibo, 00613, Puerto Rico
-
Florida Eye Associates
Melbourne, Florida, 30394-7344, United States
-
Gloucestershire Hospitals NHS Foundation Trust
Gloucestershire, GL1 3NN, United Kingdom
-
Grupo Laser Vision
Rosario, S2000DLA, Argentina
-
Hadassah MC
Jerusalem, 9112001, Israel
-
Institut De L'Oeil Des Laurentides
Boisbriand, Quebec, J7H 0E8, Canada
-
Kaplan Medical Center
Rehovot, 7660101, Israel
-
Kim's Eye Hospital
Seoul, 07301, South Korea
-
Kings College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
-
Niepubliczny Zak?ad Opieki Zdrowotnej PRYZMAT-OKULISTYKA
Gliwice, 44-100, Poland
-
Oftalmos
Capital Federal, C1120AAN, Argentina
-
Organizacion Medica de Investigacion
Buenos Aires, C1015ABO, Argentina
-
Pusan National University Hospital
Busan, 49241, South Korea
-
Rabin MC
Petah Tikva, 4941492, Israel
-
Rambam Medical Center
Haifa, 3109601, Israel
-
Retina Consultants of Texas
Bellaire, Texas, 77401, United States
-
Retina Institute of Ottawa
Ottawa, Ontario, K2B 7E9, Canada
-
Retina Vitreous Associates of Florida
Tampa, Florida, 33617, United States
-
Royal Surrey County Hospital
Guildford, GU2 7XX, United Kingdom
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Tel Aviv Sourasky MC
Tel Aviv, 6423906, Israel
-
Texas Retina Associates
Arlington, Texas, 76012, United States
-
Toronto Retina Institute
Toronto, Ontario, M3C 0G9, Canada
-
Verum Research LLC
Eugene, Oregon, 97401, United States
-
Win Retina
Arcadia, California, 91006, United States
-
Yeungnam University Medical Center
Daegu, 42415, South Korea
Conditions
Explore the condition pages connected to this study.